Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 46, 2018 - Issue 2
Submit an article Journal homepage
1,804
Views
19
CrossRef citations to date
0
Altmetric
Articles

Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line

Hajar ShaliTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; ;Student’s Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Mahdi ShabaniDepartment of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; View further author information
,
Fatemeh PourgholiDepartment of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Mahsa HajivaliliDepartment of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Leili Aghebati-MalekiDepartment of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Farhad Jadidi-NiaraghTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Behzad BaradaranDepartment of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Ali Akbar Movassaghpour AkbariHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; View further author information
,
Vahid YounesiPishtaz Teb Diagnostics, Tehran, Iran; ;Faculty of Paramedical Sciences, Alborz University of Medical Sciences, Karaj, Iran; View further author information
&
Mehdi YousefiLiver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; ;Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, IranCorrespondence[email protected]
View further author information
 show all
Pages 293-302 | Received 16 Oct 2016, Accepted 09 Mar 2017, Published online: 31 Mar 2017

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Xing Kang, Hijuan Wang, Yanwei Li, Ying Xiao, Lili Zhao, Tingting Zhang, Shaohe Zhou, Xiaolun Zhou, Yi Li, Zhexing Shou, Chao Chen & Bin Li. (2019) Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 1961-1970.
Read now
Maryam Afsharzadeh, Maryam Hashemi, Ahad Mokhtarzadeh, Khalil Abnous & Mohammad Ramezani. (2018) Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Artificial Cells, Nanomedicine, and Biotechnology 46:6, pages 1095-1110.
Read now

Articles from other publishers (17)

Jagabandhu Bag, Sabyasachi Banerjee, Arnab De, Sreejan Manna, Subhasis Banerjee, S. K. Ashok Kumar & Sourav De. (2023) Nanoengineered approaches to improve the efficacy of targeted drug delivery for the treatment of malignancy: a comprehensive review. Future Journal of Pharmaceutical Sciences 9:1.
Crossref
Milad Ashrafizadeh, Kiavash Hushmandi, Sepideh Mirzaei, Saied Bokaie, Ashkan Bigham, Pooyan Makvandi, Navid Rabiee, Vijay Kumar Thakur, Alan Prem Kumar, Esmaeel Sharifi, Rajender S. Varma, Amir Reza Aref, Marcin Wojnilowicz, Ali Zarrabi, Hassan Karimi‐Maleh, Nicolas H. Voelcker, Ebrahim Mostafavi & Gorka Orive. (2022) Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. Bioengineering & Translational Medicine 8:1.
Crossref
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, Sima Orouei, Kiavash Hushmandi, Maliheh Entezari, Mehrdad Hashemi, Amir Reza Aref, Michael R. Hamblin, Hui Li Ang, Alan Prem Kumar, Ali Zarrabi & Saeed Samarghandian. (2022) Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sciences 298, pages 120463.
Crossref
Jingxian Ding & Yonghong Guo. (2022) Recent Advances in Chitosan and its Derivatives in Cancer Treatment. Frontiers in Pharmacology 13.
Crossref
Mahshid Shahverdi, Khalil Hajiasgharzadeh, Amin Daei Sorkhabi, Mahdi Jafarlou, Maryam Shojaee, Neda Jalili Tabrizi, Nazila Alizadeh, Mariacarmela Santarpia, Oronzo Brunetti, Hossein Safarpour, Nicola Silvestris & Behzad Baradaran. (2022) The regulatory role of autophagy-related miRNAs in lung cancer drug resistance. Biomedicine & Pharmacotherapy 148, pages 112735.
Crossref
Cha Yee Kuen & Mas Jaffri Masarudin. (2022) Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment. Molecules 27:2, pages 473.
Crossref
Mohammad Doroudian, Mohammad H. Azhdari, Nima Goodarzi, David O’Sullivan & Seamas C. Donnelly. (2021) Smart Nanotherapeutics and Lung Cancer. Pharmaceutics 13:11, pages 1972.
Crossref
Milad Ashrafizadeh, Masoud Delfi, Farid Hashemi, Amirhossein Zabolian, Hossein Saleki, Morteza Bagherian, Negar Azami, Mahdi Vasheghani Farahani, Seyed Omid Sharifzadeh, Soodeh Hamzehlou, Kiavash Hushmandi, Pooyan Makvandi, Ali Zarrabi, Michael R. Hamblin & Rajender S. Varma. (2021) Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydrate Polymers 260, pages 117809.
Crossref
Soudeh Ghafouri-Fard, Atefe Abak, Mahdi Mohaqiq, Hamed Shoorei & Mohammad Taheri. (2021) The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia. Frontiers in Cell and Developmental Biology 9.
Crossref
David Vetvicka, Ladislav Sivak, Chinmay M. Jogdeo, Raj Kumar, Rubayat Khan, Yu Hang & David Oupický. (2021) Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?. Journal of Controlled Release 331, pages 246-259.
Crossref
Shahid Karim, Wei Meng Lim, Farrukh Zeeshan, Huda M. Alkreathy, Nabil A. Alhakamy, Hibah M. Aldawsari & Shadab Md. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs 307 335 .
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Farid Hashemi, Ebrahim Rahmani Moghadam, Mehdi Raei, Mahshad Kalantari, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi, Franklin R. Tay & Pooyan Makvandi. (2020) Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Combinatorial Science 22:12, pages 669-700.
Crossref
Tehreem Mumtaz, Maimoona Qindeel, Asim.ur.Rehman, Mohamad Tarhini, Naveed Ahmed & Abdelhamid Elaissari. (2020) Exploiting proteases for cancer theranostic through molecular imaging and drug delivery. International Journal of Pharmaceutics 587, pages 119712.
Crossref
Ke-Tao Jin, Ze-Bei Lu, Jin-Yang Chen, Yu-Yao Liu, Huan-Rong Lan, Hai-Ying Dong, Fan Yang, Yuan-Yuan Zhao & Xiao-Yi Chen. (2020) Recent Trends in Nanocarrier-Based Targeted Chemotherapy: Selective Delivery of Anticancer Drugs for Effective Lung, Colon, Cervical, and Breast Cancer Treatment. Journal of Nanomaterials 2020, pages 1-14.
Crossref
Khalil Hajiasgharzadeh, Saeed Sadigh‐Eteghad, Behzad Mansoori, Ahad Mokhtarzadeh, Dariush Shanehbandi, Mohammad Amin Doustvandi, Zahra Asadzadeh & Behzad Baradaran. (2019) Alpha7 nicotinic acetylcholine receptors in lung inflammation and carcinogenesis: Friends or foes?. Journal of Cellular Physiology 234:9, pages 14666-14679.
Crossref
Devashree Jahagirdar, Sharwari Ghodke, Akshay Mergu, Aishwarya Nikam, Padma V. Devarajan, Ratnesh Jain & Prajakta Dandekar. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis 197 228 .
Yazhou Chen, Li Zhang, Yingjie Liu, Shiming Tan, Ruidan Qu, Zirong Wu, Yue Zhou & Jing Huang. (2018) Preparation of PGA–PAE-Micelles for Enhanced Antitumor Efficacy of Cisplatin. ACS Applied Materials & Interfaces 10:30, pages 25006-25016.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.